pharmaphorum28d
Pharma stocks fall after new drug price probe in US
US politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their shares to drop suddenly. AstraZeneca, Novo Nordisk and AbbVie ...
With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
As tariffs loom and global currency values fluctuate, goods from these top US trade partners may shift in price
OANDA used Census data to see how top import prices and currency values may shift amid tariff fluctuations and ongoing ...
Morningstar9d
Weight-loss-drug price war is on, as Wegovy prices cut for monthly subscribers
The company's (NVO) move comes a week after Eli Lilly & Co. (LLY) cut prices for its rival weight-loss drug Zepbound. Novo Nordisk announced Wednesday the launch of NovoCare Pharmacy, which will ...